TP53 and acute myeloid leukemia: The tumor suppressor gene TP53 encoding the transcription factor p53 plays a crucial role in many human cancers and mutations of TP53 occur in a broad percentage of AML patients depending on the history of AML (e.g., t-AML following chemotherapy).